Summary
Quantitative electroencephalographic (QEEG) analysis was performed in rats following the oral administration of SR 41378 [3-(4-hydroxy-1-piperidinyl)-6-(2,4-dichlorophenyl)-pyridazine], a novel aminopyridazine derivative, which has been shown to possess anticonvulsant, antianxiety and hypnotic activities in mice and rats. The EEG effects of SR 41378 (10, 30 and 100 mg/kg) were compared to those of secobarbital (30 and 60 mg/kg) and diazepam (1, 3 and 10 mg/kg). SR 41378 and secobarbital increased the power of the middle-frequencies (8–16 Hz) of the EEG, reduced that of 4–8 Hz (theta) activities and did not affect 1–4 Hz (delta) activities. Diazepam also increased the power of middle-frequency activities and decreased that of both delta and theta activities. Quantitative EEG profiles were calculated from the mean integrated power (MIP) of selected frequency bands. The QEEG profile of SR 41378 was found to share common characteristics with those of secobarbital and diazepam: dose-dependent decrease of theta band MIP and increase of 8–20 Hz (middle beta bands) MIP. However, both SR 41378 and secobarbital induced a reduction of the 28–32 Hz (fast beta bands) MIP, whereas diazepam diminished the delta band. These results suggest that SR 41378, a novel chemical structure, shares common psychotropic properties with barbiturates and benzodiazepines.
This is a preview of subscription content, log in via an institution to check access.
References
Bente D (1956) Elektroencephalographische Ergebnisse zur Wirkungsweise der neuroleptischen Behandlungsverfahren. L'Encéphale 45:898–903
Bizière K, Calassi R, Perio A, Terranova J-P (1985a) Antianxiety activity of SR 41378, a new non-benzodiazepine hypnotic. Br J Pharmac (Suppl) 84:116
Bizière K, Calassi R, Chambon J-P, Hallot A, Michaud J-C (1985b) SR 41378 a new potential hypnotic drug with anticonvulsant properties. Br J Pharmacol (Suppl) 84:198
Fairchild MD, Jenden DJ, Mickey MR, Yale C (1980) The quantitative measurement of changes in EEG frequency spectra produced in the cat by sedative-hypnotics and neuroleptics. Electroencephalogr Clin Neurophysiol 49:382–390
Fink M (1963) Quantitative EEG in human psychopharmacology: drug patterns. In: Glaser GH (ed) EEG and behavior. Basic Books, New York, pp 177–197
Gehrmann JE, Killam KF Jr (1976) Assessment of CNS drug activity in rhesus monkeys by analysis of the EEG. Fed Proc 35:2258–2263
Hallot A, Brodin R, Merlier J, Brochard J, Chambon J-P, Bizière K (1986) Synthesis and activity of 6-aryl-3-(hydroxycycloalkylamino)-pyridazines and animal models of epilepsy. J Med Chem 29:369–375
Herrmann WM (1981) Some examples for the possibilities and limitations of pharmaco-electroencephalography as a method in clinical pharmacology. Methods Find Exp Clin Pharmacol 3 (Suppl 1):55S-76S
Itil TM (1971) Quantitative pharmaco-electroencephalography in assessing new antianxiety agents. In: Vinar O, Votava Z, Bradley PB (eds) Advances in neuro-psychopharmacology. North Holland Publishing Co, Amsterdam, pp 199–209
Itil TM, Hsu W, Cig E (1973) “Anxiolytic” profile and “bioavailability” of clorazepate dipotassium based on quantitative pharmaco-electroencephalography. Agressologie 14:203–212
Itil TM, Saletu B, Akpinar S (1974) Classification of psychotropic drugs based on digital computer sleep prints. In: Itil TM (ed) Modern problems in pharmacopsychiatry, vol 8: Psychotropic drugs and the human EEG. Karger, Basel, pp 193–215
Itil TM, Huque M (1979) Computer EEG profiles of anxiolytics (quantitative pharmaco-EEG in the development of new anxiolytics). In: Fielding S, Lal H (eds) Industrial pharmacology. Futura Publishing Co, New York, pp 281–316
Mariotti M, Ongini E (1983) Differential effects of benzodiazepines on EEG activity and hypnogenic mechanisms of the brain stem in cats. Arch Int Pharmacodyn 264:203–219
Namura I, Saito Y, Takahashi Y (1981) Quantitative EEG analysis of hypnotic-induced fast waves. Electroencephalogr Clin Neurophysiol 52:S92
Ongini E, Barzaghi C, Marzanatti M (1983) Intrinsic and antagonistic effects of beta-carboline FG 7142 on behavioral and EEG actions of benzodiazepines and pentobarbital in cats. Eur J Pharmacol 95:125–129
Saletu B, Grünberger J, Linzmayer L, Flener R (1981) Anxiolytics and betablockers: Evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables. Agressologie 22:5–16
Sannita WG, Rapallino MV, Rodriguez G, Rosadini G (1980) EEG effects and plasma concentrations of phenobarbital in volumteers. Neuropharmacology 19:927–930
Schwartz J, Feldstein S, Fink M, Shapiro DM, Itil TM (1971) Evidence for a characteristic EEG frequency response to thiopental. Electroencephalogr Clin Neurophysiol 31:149–153
Shapiro SS, Wilk MB (1965) An analysis of variance test for normality (complete samples). Biometrika 52:591–611
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santucci, V., Rocher, D., Veyrun, J. et al. Quantitative electroencephalographic profile of 3-(4-hydroxy-1-piperidinyl)-6-(2,4-dichlorophenyl)-pyridazine (SR 41378) in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 186–189 (1986). https://doi.org/10.1007/BF00506525
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506525